Ad
related to: moderna vaccine
Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 16 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 5 hours agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 2 days agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 13 hours agoOther nations' regulatory bodies followed suit. The rest, as they say, is history. Pandemic-prompted...
Moderna’s Promise of mRNA Undercut by New RSV Vaccine
Bloomberg· 11 hours agoConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly...
Bird Flu: 100 Million Doses of Vaccine Could Be Shipped Within Months
Healthline· 2 days agoThe U.S. government has two candidate vaccine viruses for H5N1 bird flu that could be used to make...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 10 hours agoOn Thursday, Deutsche Bank (ETR:DBKGn) revised its price target for Moderna (NASDAQ:MRNA) shares,...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 14 hours agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Sisk selected for MITC fit-out in Oxfordshire
World Construction Network via Yahoo Finance· 13 hours agoModerna’s new drug substance and manufacturing facility in Oxfordshire, England, UK. The Moderna Innovation and Technology Centre (MITC) development,...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
